Verticalizer Erigo in Turkey: what it is and how it works
The verticalizer erigo is a specialized robotic mobilization system manufactured by Hocoma for the early rehabilitation of bedridden, severely impaired, or neurologically compromised patients. Combining a motorized tilt table with robotic footplates and synchronized functional electrical stimulation (FES), the device supports patients who cannot stand or initiate leg movements independently. In Turkish neurorehabilitation centres, medical teams use the device in acute and subacute settings to begin vertical mobilization as early as possible following traumatic brain injury, stroke, or spinal cord trauma.
Prolonged bed rest poses severe risks to neurological patients, including cardiovascular deconditioning, deep vein thrombosis, joint contractures, and pneumonia. Understanding what is verticalizer erigo technology involves examining how it addresses these hazards: it safely tilts the body from a horizontal position up to an angle of 75 to 80 degrees while continuously moving the lower limbs in a physiological stepping pattern. This guide explains how the system functions, what clinical studies confirm, what verticalizer erigo rehabilitation costs across Turkey, the UK, the US, and Germany, and how to assess accredited clinics. For an overview of specialized programmes, explore rehabilitation treatments in Turkey.
How does the Erigo robotic tilt-table work?
The device operates by integrating three distinct therapeutic mechanisms into one continuous session: progressive verticalization, mechanical cyclic leg movement, and functional electrical stimulation. Each mechanism addresses a specific physiological barrier created by prolonged immobility.
When an immobilized person is raised upright, gravity causes blood to pool in the abdomen and lower extremities, frequently triggering orthostatic hypotension (a sharp drop in blood pressure) and fainting. The Erigo counters this through automated stepping footplates. As the table tilts upright in gradual increments, motorized foot drives flex and extend the knees and hips in an alternating pattern that mimics natural human walking. This rhythmic motion activates the calf and thigh muscle pump, compressing deep venous vessels and propelling blood back toward the heart.
Simultaneously, computer-controlled functional electrical stimulation delivers synchronized electrical impulses to major muscle groups, including the quadriceps and gastrocnemius, during the corresponding phase of each simulated step. This active muscle contraction further stabilizes arterial blood pressure and sends vital proprioceptive sensory signals through the spinal cord up to the sensorimotor cortex. By providing continuous afferent feedback, verticalizer erigo therapy stimulates neuroplasticity and early neural reorganization, which are fundamental principles in modern neurological rehabilitation.
Does verticalizer Erigo therapy actually work?
Evaluating does verticalizer erigo work requires looking at published clinical trials and neurorehabilitation consensus guidelines rather than commercial claims. Research documented in neurological journals demonstrates clear benefits for specific physiological targets, while also defining clear boundaries for what the technology cannot achieve.
The strongest clinical evidence supports the device's role in cardiovascular stabilization during early mobilization. Comparative trials consistently show that patients mobilized on the Erigo maintain higher mean arterial pressure, experience significantly fewer episodes of presyncope or fainting, and tolerate vertical angles of 60 to 75 degrees far earlier than patients placed on passive tilt tables. Evidence also demonstrates effective preservation of ankle and knee range of motion, reduction in lower-extremity hypertonia and spasticity, and reduction in the incidence of orthostatic intolerance in intensive care units.
In patients with severe disorders of consciousness following traumatic brain injury or anoxia, repetitive upright sensory stimulation has been shown to improve cerebral blood flow and enhance behavioural alertness scores. However, medical teams emphasize that the Erigo is not a standalone cure for paralysis. It does not regenerate severed spinal nerve tracts or replace active task-specific walking practice at later stages. Its proven purpose is early cardiovascular conditioning and physiological preparation, enabling patients to transition safely toward intensive physical therapy.
Verticalizer Erigo cost in Turkey compared with the UK, US and Germany
Robotic mobilization is not provided as an isolated outpatient visit; it is delivered as part of an intensive, inpatient neurorehabilitation programme. The figures below represent approximate cost ranges for multi-week inpatient rehabilitation packages, rather than single-session clinic quotes. Exact fees depend on the required medical dependency tier and diagnostic evaluations.
| Country | Approximate cost range |
|---|---|
| Turkey | €2,500 – €8,000 |
| United Kingdom | €7,000 – €22,000 |
| United States | €10,000 – €30,000 |
| Germany | €6,500 – €20,000 |
Several clinical factors influence the verticalizer erigo cost. The overall duration of admission—typically ranging from two to six weeks—is the primary driver. The level of nursing care also determines expenses: an intensive care or high-dependency bed with continuous cardiac telemetry costs substantially more than a standard subacute rehabilitation room. The verticalizer erigo price is further shaped by the frequency of robotic sessions (normally three to five per week) combined with daily physical therapy, occupational therapy, and respiratory care.
In Turkish rehabilitation hospitals, an international package generally covers hospital accommodation for the patient and an accompanying family member, daily physician assessments by physiatrists and neurologists, nursing care, robotic and manual therapy sessions, routine medications, and airport transfers. Patients and families should request an itemised written quotation to verify exactly which services are included.
Erigo verticalizer, Lokomat or standard tilt table?
Neurorehabilitation facilities employ different technological tools depending on the patient's phase of recovery, trunk stability, and weight-bearing ability. Choosing verticalizer erigo Turkey programmes is appropriate for early acute and subacute recovery, whereas other devices become relevant as recovery advances.
| Device / Method | Best suited to | Typical limits |
|---|---|---|
| Verticalizer Erigo | Early mobilization, severe immobility, acute stroke, low blood pressure tolerance | Preparatory mobilization; does not replicate overground walking |
| Standard tilt table | Basic passive upright conditioning, orthostatic tolerance screening | High incidence of syncope; lack of active leg movement or FES |
| Lokomat gait trainer | Subacute to chronic gait re-education, active step initiation | Requires trunk stability and upright tolerance; unsuitable for bedridden patients |
A standard tilt table provides only passive inclination without leg motion or electrical stimulation, which leaves patients vulnerable to blood pooling and sudden drops in blood pressure. The Lokomat, by contrast, is a robotic exoskeleton suspended over a treadmill, engineered for active gait training; however, it requires the patient to tolerate full upright verticality and possess sufficient head and trunk control. The Erigo bridges the critical gap between complete bed rest and upright gait training, making it particularly valuable in stroke rehabilitation where early mobilization must precede weight-bearing practice.
Who is a candidate for verticalizer Erigo, and who is not?
Appropriate patient selection is vital for safety and therapeutic success. A specialist in Physical Medicine and Rehabilitation (PM&R) conducts a comprehensive screening before prescribing robotic verticalization.
Good candidates include:
- Subacute stroke patients presenting with severe hemiplegia who cannot stand or tolerate sitting unsupported.
- Patients recovering from moderate-to-severe traumatic brain injury (TBI) or hypoxic-ischaemic brain injury, including those in minimally conscious states.
- Individuals with incomplete or complete spinal cord trauma requiring cardiovascular reconditioning and spasticity management; see our guide to spinal cord injury rehabilitation.
- Patients with critical illness polyneuropathy, prolonged intensive care bed rest, or severe disuse muscular atrophy.
Patients who are not suitable for the procedure include those with unhealed fractures of the pelvis, spine, or lower extremities, as mechanical stepping imposes shear forces. Severe fixed joint contractures in the hips, knees, or ankles that prevent anatomical positioning also rule out treatment. Additional contraindications include acute untreated deep vein thrombosis, severe open pressure ulcers (grades 3 or 4) on sacral or load-bearing areas, uncontrolled cardiac arrhythmias, acute myocardial infarction, and severe autonomic dysreflexia in high spinal cord lesions that cannot be managed with medication.
What happens during an Erigo mobilization session?
A standard therapy session lasts between 30 and 45 minutes and is conducted by a trained neurorehabilitation physiotherapist under medical supervision. The procedure follows six defined clinical steps.
First, the therapist conducts a baseline pre-session examination, recording resting blood pressure, heart rate, oxygen saturation, and inspecting skin integrity on harness contact points. Second, the patient is transferred using a hoist or sliding sheet onto the cushioned Erigo table while it rests in a completely horizontal (0-degree) position. Padded chest and pelvic harnesses are fastened securely to support body weight, and the patient's feet are positioned into adjustable robotic footplates with secure bindings.
Third, if functional electrical stimulation is prescribed, surface electrodes are applied over the motor points of the quadriceps and calf muscles. Fourth, the robotic footplates initiate cyclical leg movement while the table remains flat, allowing the patient's muscles and circulation to adjust to the mechanical rhythm. Fifth, the physiotherapist gradually increases the tilt angle in small increments—typically 10 to 15 degrees every few minutes—monitoring blood pressure continuously. The stepping rate is adjusted between 20 and 50 steps per minute according to clinical goals. Finally, once the treatment time concludes, the table is smoothly returned to the horizontal position for a five-minute rest period and vital signs check.
Inpatient stay in Turkey and neurorehabilitation milestones
International patients travelling to Turkey for specialized neurorehabilitation generally undergo an admission lasting between two and six weeks. Planning verticalizer erigo recovery requires understanding the progressive clinical milestones achieved across the hospital stay.
During the first week, the multidisciplinary team performs comprehensive baseline diagnostics, including neurological scoring, spasticity evaluation, and blood pressure telemetry. Erigo sessions begin at conservative tilt angles (30 to 45 degrees) to establish baseline orthostatic tolerance. In weeks two and three, therapists progressively advance the tilt angle toward 60 to 75 degrees, increase stepping cadence, and combine mobilization with trunk stabilization exercises, occupational therapy, and respiratory physiotherapy.
By weeks four to six, patients demonstrating stabilized blood pressure and improved motor readiness often transition from the Erigo to advanced standing frames, hydrotherapy, or robotic gait devices such as the Lokomat. International patient coordination departments in Turkish hospitals assist with medical transfer logistics, accessible hotel lodging for relatives, interpreter services, and coordination of medical escorts for flights home.
Realistic rehabilitation outcomes: what Erigo can and cannot achieve
Setting realistic expectations is essential for patients, families, and caregivers. Neurological recovery is an incremental, biological process that demands time and consistency.
Realistic clinical achievements include the restoration of cardiovascular stability, allowing patients to tolerate sitting in a wheelchair for extended periods without syncope or dizziness. Families can also expect marked reductions in lower-limb spasticity, preservation of joint mobility, reduced incidence of pressure sores, and notable gains in daytime alertness and interaction in patients with impaired consciousness. These improvements provide the physiological foundation necessary for subsequent active rehabilitation.
Conversely, caregivers must recognize what the device cannot accomplish. The Erigo cannot unilaterally restore independent walking, eliminate paralysis caused by complete spinal transection, or replace comprehensive multidisciplinary care. Beware of marketing claims depicting instant recovery after a handful of sessions. Authentic progress in neurorehabilitation is measured through steady, verifiable physiological milestones rather than sudden breakthroughs.
Risks and safety considerations during robotic verticalization
While the Erigo is engineered with built-in safety controls, verticalizing severely impaired patients involves physiological risks that require careful clinical governance. Regulatory bodies such as the UK National Institute for Health and Care Excellence (NICE) and international neurorehabilitation societies stress the importance of supervised robotic protocols.
The primary physiological risk is orthostatic hypotension, which occurs if blood pressure drops rapidly during upward tilting. The Erigo's continuous stepping motion and electrical stimulation significantly reduce this danger compared to passive tilt tables; nonetheless, if pressure falls below safe thresholds, therapists instantly lower the tilt angle. Skin shearing and pressure friction from harnesses and leg bindings represent another potential risk, which therapists prevent by utilizing medical padding and performing routine skin checks. In patients with spinal cord injury above the T6 thoracic level, autonomic dysreflexia—a sudden, severe surge in blood pressure triggered by tight straps or bladder fullness—is a known hazard that requires immediate clinical intervention. Consequently, therapy must always occur in an accredited facility equipped with continuous monitoring and emergency medical response capabilities.
How to choose a neurorehabilitation clinic and red flags
Selecting an appropriate hospital for robotic neurorehabilitation requires rigorous scrutiny of clinical credentials. Patients and families should verify that the hospital is fully licensed by the Turkish Ministry of Health and holds recognized hospital accreditation, such as Joint Commission International (JCI).
Ensure that the rehabilitation department is directed by board-certified physiatrists and staffed by physical therapists certified in robotic rehabilitation devices. The facility should possess on-site diagnostic imaging (MRI, CT), intensive care units, and round-the-clock emergency medical teams to handle any acute complications. Be alert to red flags: clinics that promise complete recovery from paralysis, facilities lacking physician supervision during robotic sessions, quotes with undisclosed hidden fees, and coordinators who press for immediate deposits before a medical specialist has evaluated the patient's records.
Questions to ask the clinic before booking include:
- Which physical medicine and rehabilitation physician will oversee the treatment plan?
- How many sessions on the Erigo and other robotic devices are scheduled each week?
- What emergency protocols and intensive care facilities are available on site if complications arise?
- Does the quoted price include inpatient room accommodation, nursing, and interpreter support?
- What clinical reports and imaging files are needed for the initial medical assessment?
To understand the admission process, review how it works and submit the patient's recent medical summary through our free quote form to receive a detailed evaluation and written plan.
Hospitals with Rehabilitation in Turkey
Frequently asked questions
The verticalizer Erigo is an advanced robotic tilt-table device used in early neurological rehabilitation. It gently raises bedridden or severely impaired patients into an upright position while motorized footplates move the legs in a cyclical stepping pattern. Synchronized electrical stimulation activates leg muscles, supporting blood pressure regulation, circulation, and brain-to-muscle neural pathways.
Clinical research demonstrates that the Erigo effectively stabilizes cardiovascular parameters, counters orthostatic hypotension, and prevents circulatory collapse during early verticalization. It helps maintain joint flexibility, reduce muscle spasticity, and promote sensory feedback to the spinal cord. While it is not a standalone cure, it serves as an effective foundation for progressive neurological recovery.
In Turkey, robotic neurorehabilitation including Erigo sessions typically costs between €2,500 and €8,000 for a multi-week inpatient programme. This compares with €7,000 to €22,000 in the UK and €10,000 to €30,000 in the US. Total cost depends on nursing needs, length of hospital stay, and accompanying medical therapies.
Before therapy, patients are often bedridden, unable to tolerate an upright stance without fainting, and experiencing low muscle tone or severe stiffness. After several weeks of progressive sessions, patients typically demonstrate improved cardiovascular tolerance to vertical posture, enhanced alertness, decreased spasticity, and greater readiness for intensive gait training.
A standard tilt table raises a patient passively without leg movement, carrying a higher risk of fainting. Lokomat is a robotic gait orthosis that trains walking on a treadmill for patients who can already stand upright. Erigo bridges this gap, providing automated stepping and circulatory support for bedridden patients.
A standard course of Erigo mobilization involves three to five sessions per week, with each session lasting 30 to 45 minutes. A typical early-stage neurorehabilitation programme spans two to six weeks, adjusted according to the patient's neurological condition, cardiovascular adaptation, and physical therapy progression.
The procedure does not cause pain. Patients are securely supported by padded chest harnesses, thigh straps, and foot bindings. Because the leg movements are passive and guided by robotic motors, the patient does not need to exert physical effort. Physiotherapists monitor comfort, blood pressure, and heart rate continuously throughout each session.
Robotic verticalization is considered very safe when performed under medical supervision. Continuous cardiovascular monitoring, gradual angle elevation, and automated leg movement prevent sudden blood pressure drops. Contraindications such as unhealed lower-limb fractures, acute deep vein thrombosis, or severe cardiac instability are screened out before treatment begins.
No medical device can restore walking overnight or reverse complete neurological paralysis. Erigo is an early therapeutic tool designed to prevent immobility complications, condition the heart and blood vessels, and stimulate neural recovery. It prepares the patient for subsequent stages of physical therapy and active gait re-education.
International patients travelling to Turkey for inpatient neurorehabilitation usually stay between three and six weeks. This duration allows the multidisciplinary team to conduct comprehensive baseline evaluations, carry out a structured protocol of daily robotic sessions, and safely prepare the patient for the journey home.